2,155 Followers on Owler
OverviewCompetitorsAcquisitionsInvestmentsNews & Insights

Shire Competitors or Alternatives

Shire's top competitors include Pfizer, SOBI and Bayer .

Unlock 24 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Shire's company profile

CEO

- -
10,000 - 50,000
$0
$10B - 50B
  • $0
    $10B - 50B
  • 10,000 - 50,000
    $0
  • $10B - 50B
  • - -
  • 10,000 - 50,000
  • $0
  • $10B - 50B
View ProfileView
1
Shire's Competitor - Pfizer logo

Albert Bourla

Chairman & CEO

75/100
83,000
$1B
$63.7B
  • $1B
    $63.7B
  • 83,000
    $1B
  • $63.7B
  • 75/100
  • 83,000
  • $1B
  • $63.7B
View ProfileView
2
Shire's Competitor - SOBI logo

Guido Oelkers

President & CEO

48/100
1,840
- -
$2.7B
  • - -
    $2.7B
  • 1,840
    - -
  • $2.7B
  • 48/100
  • 1,840
  • - -
  • $2.7B
View ProfileView
3
Shire's Competitor - Bayer logo

William N. Anderson

CEO

58/100
87,757
$3.8B
$54.1B
  • $3.8B
    $54.1B
  • 87,757
    $3.8B
  • $54.1B
  • 58/100
  • 87,757
  • $3.8B
  • $54.1B
View ProfileView
4
Shire's Competitor - Sanofi logo

Belen Garijo

CEO

75/100
82,878
$4.7B
$42.4B
  • $4.7B
    $42.4B
  • 82,878
    $4.7B
  • $42.4B
  • 75/100
  • 82,878
  • $4.7B
  • $42.4B
View ProfileView
5
Shire's Competitor - Octapharma logo

Wolfgang Marguerre

Chairman & CEO

74/100
5,000 - 10,000
- -
$1B - 5B
  • - -
    $1B - 5B
  • 5,000 - 10,000
    - -
  • $1B - 5B
  • 74/100
  • 5,000 - 10,000
  • - -
  • $1B - 5B
View ProfileView
Shire's top 27 competitors are Pfizer, SOBI, Bayer , Novo Nordisk, Sanofi, Octapharma, Alnylam, Roche, Genentech, BioMarin, Sangamo, Amgen, Novartis, Gilead Sciences, Merck, Bristol-Myers Squibb, Lilly, GSK, Abbott, Johnson & Johnson, AbbVie, AstraZeneca, Salix Pharmaceuticals, Teva, Mylan, Biogen and Cipla. Together they have raised over 128.9B between their estimated 1.3M employees. Shire's revenue is the ranked 19th among it's top 10 competitors. The top 10 competitors average 35.9B. Shire has 23,044 employees and is ranked 19th among it's top 10 competitors. The top 10 competitors average 47,823.

Shire VS Pfizer

Pfizer is seen as one of Shire's top competitors. Pfizer was founded in New York, New York} in 1849. Pfizer is in the Pharmaceuticals industry. Compared to Shire, Pfizer generates $48.5B more revenue.

Shire VS SOBI

SOBI is Shire's #2 competitor. SOBI was founded in 2010, and its headquarters is in Stockholm, Stockholms län. SOBI competes in the Pharmaceuticals industry. SOBI has 21,204 fewer employees than Shire.

Shire VS Bayer

Bayer is Shire's #3 rival. Bayer is headquartered in Leverkusen, North Rhine-Westphalia, and was founded in 1863. Like Shire, Bayer also competes in the Pharmaceuticals industry. Bayer generates 356% the revenue of Shire.

Looking for similar companies to Shire?

Similar Companies

Biotechnology companies with employees in 10-50K range

See 20 companies 
Pharmaceuticals companies with revenue in $10-50B range

See 32 companies 
Pharmaceuticals & Biotechnology companies with revenue in $10-50B range

See 41 companies 
Biotechnology companies in Zug

See 22 companies 
Pharmaceuticals companies in Zug

See 24 companies 
Pharmaceuticals & Biotechnology companies in Zug

See 41 companies 
Companies in Switzerland with revenue in $10-50B range

See 43 companies 
Companies in Switzerland with employees in 10-50K range

See 81 companies 
Pharmaceuticals companies with employees in 10-50K range

See 83 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Shire and Shire's Competitors

September 4, 2026PMLiVE
The 2026-2027 vaccine targets the XFG variant to more closely match current variants...
September 5, 2026Quartz
Novartis paused 8 trials of its rap-cel therapy after patients died from a severe immune reaction; Bristol Myers followed as a precaution...
September 4, 2026Benzinga
Eric George Davis, EVP at BioMarin Pharmaceutical (NASDAQ:BMRN), reported an insider sell on September 3, according to a new SEC filing. What Happened:...
September 5, 2026Nasdaq
Key PointsGilead is best known for its dominant HIV franchise....
September 5, 2026Quartz
Novartis paused 8 trials of its rap-cel therapy after patients died from a severe immune reaction; Bristol Myers followed as a precaution...
September 5, 2026Pulse2.0
Superluminal Medicines has raised an oversubscribed $60 million Series B financing led by BVF Partners to advance its lead obesity program into clinica...
September 4, 2026Businessinsider
Wells Fargo raised the firm's price target on Amgen ( AMGN ) to $435 from $400 and keeps an Equal Weight rating on the shares. Given where the stock cu...
September 4, 2026Benzinga
Highlighted on September 4, it was unveiled in an SEC filing that Schmid, EVP at Johnson & Johnson (NYSE:JNJ), executed a significant transaction invol...
September 4, 2026Contract Pharma
GSK gains rights outside Greater China to develop HMPL-A830 for KRAS-altered tumors....
September 4, 2026Korea Biomedical Review
Pfizer Korea said Friday that its tumor necrosis factor (TNF) inhibitor Enbrel (etanercept) has gained national health insurance reimbursement for pati...

Frequently Asked Questions about Shire

  1. Who are Shire's top competitors?

    Shire's top 3 competitors are Pfizer, SOBI, Bayer .

  2. Who is similar to Shire?

    Pfizer is the most similar to Shire. SOBI and Bayer are also similar to Shire.

  1. Are Shire and Pfizer competitors?

    Yes, Pfizer is one of Shire’s top competitors.